GTC Biotherapeutics (fka GTCB)

[jessellivermore]

VIN....

"Traitor, deserter"... but accusing me of pump and dumping ( I owned shares of GTC in the nineties) is ludicrous. Perhaps you will take the time to read one of my posts for a change. The below was posted in early Dec 2008, you may notice some similaries in it to my "new found objectivity." Also prior to the FDA approval I did very little posting a fact noted by GS in a PM.

Post 15897 Posted Dec 12, 2008


The Problem with GTCB is.......

In the Black Arts it is said, in order to call up a demon, you must first learn his name.

In a comparable manner, to solve GTC's ploblem, we must first correctly identify it. Poor management decisions such a stock buykbacks, loss of product, or poor negotiating technique, are superficial and relatively trivial issues and do not address the serious root problem. The Problem, the root problem is Big Pharma's (BP) failure to embrace GTC's novel protien production platform (NPPP), ie mammalian transgenics.

Implied in GTC's long term business plan was BP would understand the advantages of the NPPP, chiefly lower production cost, and greater virtuousity in terms of producing proteins which are difficult to express in vat systems. GTC would sustain its operations and prosper via numerous partnerships with BP. It was anticipated these partnerships would be instituted after a regulatory approval. This has obviously not occurred. The question is why???

Someone posted the Jerry MaGuire tag,,,Show me the money.
The reason why why BP has not embraced GTC, even for the piddling amounts GTC needs to survive is the NPPP offers BP no financial incentives, and indeed poses a threat to BP.

Since the 1950s, when the Keffauver Commitee investigated the Drug Industry,BP has been acutely aware of their profit margins. BP is a unique industry because it has pretty much the ability to set its profit margins at any level it wants. The sick and dying are not in a very good negotiating position. BP's only real constraints on profit margins are the fact they are closely watched by congress. The normal rules of business do not apply in an industry where the FDA awards long term franchises which are defacto monopolies. The cost of production....BP does not give a flying f*** about the cost of production, as long as they do not excede +25% profit, who cares what it costs to make,,the customer will pay the difference. Can't make enough of the stuff,,no problem just increase the price and call it supply and demand.

What is BP's attitude toward new technology??? Well the GTC case lays it out pretty clearly....they don't give a crap about it. Rich people do not as a rule embrace change. In fact change is just about the scariest thing the rich can think of.

This I summit is the The Problem . We need solutions, please feel free with your ideas. I will post some of mine later.

Regards ":>)JL

How's my "pumping" in this one Vin ????